Nine Point Two Capital LLC Bridge Bio Pharma, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 8,442 shares of BBIO stock, worth $272,761. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,442
Previous 8,442
-0.0%
Holding current value
$272,761
Previous $222,000
53.15%
% of portfolio
0.14%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$816 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$812 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$402 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$200 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.79B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...